The Renal Elimination Pathways of the Dabigatran Reversal Agent Idarucizumab and its Impact on Dabigatran Elimination

Idarucizumab, a humanized monoclonal antibody fragment (Fab), provides rapid and sustained reversal of dabigatran-mediated anticoagulation. Idarucizumab and dabigatran are mainly eliminated via the kidneys. This analysis aimed to characterize the renal elimination of idarucizumab and investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Glund, Stephan, Gan, Guanfa, Moschetti, Viktoria, Reilly, Paul, Honickel, Markus, Grottke, Oliver, Van Ryn, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714879/
https://www.ncbi.nlm.nih.gov/pubmed/29534609
http://dx.doi.org/10.1177/1076029618755947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6714879/
https://www.ncbi.nlm.nih.gov/pubmed/29534609
http://dx.doi.org/10.1177/1076029618755947

Ejemplares similares